| DAIC

August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance (MR) conditional labeling for all previously implanted Emblem S-ICD Systems.

The new Emblem MRI S-ICD System is the latest addition to the Boston Scientific's growing line of ImageReady MR-conditional electrophysiology devices, which allow patients to undergo magnetic resonance imaging (MRI) safely.

Read more about FDA Clears MRI-safe Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System

August 9, 2016 – With the use of intensive care units (ICUs) on the rise in many hospitals, researchers at LA BioMed and University of California, Los Angeles (UCLA) examined ICU usage and found patients who were admitted to these units underwent more costly and invasive procedures, but didn’t have better mortality rates than hospitalized patients with the same medical conditions who were not admitted to the ICU.

Read more about Higher ICU Usage for Heart Failure, PE Led to Increased Invasive Procedures and Costs

Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart.

Read more about AAN: PFO Closure Not Recommended for People with Heart Defect and Stroke

ClearFlow Inc. announced in late July that its PleuraFlow Active Clearance Technology is now available for the treatment of pediatric cardiothoracic surgery patients.